Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 2, 2004, Pages 376-384

  Woolley, Steven M ^a   Farivar, Alexander S ^a   Naidu, Babu V ^a   Rosengart, Matthew ^a   Thomas, Robert ^a   Fraga, Charles ^a   Mulligan, Michael S ^a   Keenan, Robert J ^b   Egan, Thomas M ^b   Cassivi, Stephen D ^b   Korst, Robert J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENDOTRACHEAL INTUBATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INJURY SCALE; ISCHEMIA; LEUKOCYTE; LUNG INJURY; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 10744228106     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.09.034     Document Type: Article

References (24)

1. Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg. 1999;230:362-70.
2. Wittwer T, Wahler T, Fehrenbach A, Elki S, Haverich A. Improvement of pulmonary preservation with Celsior and Perfadex: impact of storage time on early post-ischemic lung function. J Heart Lung Transplant. 1999;18:1198-201.
3. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res. 1995;58:713-8.
4. Baeuerle PA, Baltimore D. NF-κB: ten years later. Cell. 1996;87:13-20.
5. Giordani F, Benetolli A, Favero-Filho LA, Lima KC, Cestari Junior L, Milani H. Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: a 7- and 30-day study. Braz J Med Biol Res. 2003;36:495-502.
6. Yang CW, Ahn HJ, Han HJ, Kim WY, Li C, Shin MJ, et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation. 2001;72:1753-9.
7. St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl. 2003;9:144-9.
8. Squadrito F, Altavillla D, Squadrito G, Saitta A, Deodat B, Arlotta M, et al. Tacrolimus limits polymorphonuclear accumulation and protects against myocardial ischemia-reperfusion injury, J Mol Cell Cardiol, 2000;32:429-40.
9. Krishnadasan B, Naidu B, Rosengart M, Barnes A, Verrier ED, Mulligan MS, et al. Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg. 2002;123:756-67.
10. Naidu BV, Krishnadasan B, Byrne K, Rosengart M, Verrier ED, Mulligan MS, et al. Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann Thorac Surg. 2002;74:899-905.
11. Meyer S, Kohler G, Joly A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation. FEBS Lett. 1997;413:354-8.
12. Hughes K, Antonsson A, Grundstrom T. Calmodulin dependence of NfkappaB activation. FEBS Lett. 1998;44:132-6.
13. Travis DL, Fabia R, Netto GG, Husberg BS, Goldstein RM, Klintman GB, et al. Protection by cyclosporine A against normothermic liver ischemia-reperfusion in pigs. J Surg Res. 1998;75:116-26.
14. Dhar DK, Takemoto YI, Nagasue N, Uchida M, Ono T, Nakamura T. FK-506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. J Surg Res. 1996;60:142-6.
15. Puglisi RN, Strande L, Santos M, Scheulte G, Hewitt CW, Whalen TV. Beneficial effects of rapamycin and cyclosporine in small bowel ischemia-reperfusion injury. J Surg Res. 1996;65:115-18.
16. Weinbrenner C, Liu GS, Downey JM, Cohen MV. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res. 1998;38:678-84.
17. Furuichi Y, Katsuta K, Maeda M, Ueyama N, Moriguchi A, Matsuoka N, et al. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy. Brain Res. 2003;965:137-45.
18. Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2003;126:200-7.
19. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, et al. Early TNF-α release from the pulmonary macrophage in lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2004; in press.
20. Mulligan MS, Vaporciyan AA, Warner RL, Jones ML, Foreman KE, Miyasaka M, et al. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol. 1995;154:1350-63.
21. St Peter SD, Moss AA, Mulligan DC. Effects of tacrolimus on ischemia-reperfusion injury. Liver Transpl. 2003;9:105-16.
22. Wakabayashi H, Karasawa Y, Tanaka S, Kokudo Y, Maeba T. The effect of FK506 on warm ischemia and reperfusion injury in the rat liver. Surg Today. 1994;24:994-1002.
23. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion induced damage in isolated rat hearts. J Mol Cell Cordial. 1993;25:1461-9.
24. Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg. 2001;121:1069-75.